These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2709242)

  • 1. Cleanliness assessment of supplier-cleaned stoppers.
    Townsend MW; Conti B; Hazrati A; DeLuca PP
    J Parenter Sci Technol; 1989; 43(2):98-102. PubMed ID: 2709242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Particulate matter test in small volume parenterals: critical aspects in sampling methodology.
    Pavanetto F; Conti B; Genta I; Ponci R; Montanari L; Grassi M
    Farmaco; 1989 Jun; 44(6):633-43. PubMed ID: 2803449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Particulate-matter content of 11 cephalosporin injections: conformance with USP limits.
    Parkins DA; Taylor AJ
    Am J Hosp Pharm; 1987 May; 44(5):1111-8. PubMed ID: 3605122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on particle contamination produced by syringe needles and rubber stoppers for pharmaceutical solutions].
    Zhao L; Wang HS; Han ZF
    Zhonghua Hu Li Za Zhi; 1997 Jan; 32(1):12-4. PubMed ID: 9304949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Particulate contamination from siliconized rubber stoppers--a statistical evaluation.
    Li LC; Parasrampuria J; Tian Y
    J Parenter Sci Technol; 1993; 47(5):270-3. PubMed ID: 8263665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of different rubber stoppers; the effect of sterilization on the number of particles released.
    Mannermaa JP; Muttonen E; Yliruusi J; Juppo A
    J Parenter Sci Technol; 1992; 46(3):73-7. PubMed ID: 1522444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of methods for detection of particulate matter in large-volume perenterals.
    Blanchard J; Thompson CM; Schwartz JA
    Am J Hosp Pharm; 1976 Feb; 33(2):144-50. PubMed ID: 1258874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Filtering effectiveness of conventional 15 m micron filters (DIN 58362) and newly developed 15 m micron and 5 m micron filters. I: Particle count].
    Walpot H; Franke RP; Burchard WG; Agternkamp C; Müller FG; Mittermayer C; Kalff G
    Infusionstherapie; 1989 Apr; 16(2):77-80. PubMed ID: 2737765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of factors influencing ampoule secondary particulate contamination. A strategy for its reduction in small volume parenterals.
    Bernuzzi M; Raggi P; Montanari L
    Boll Chim Farm; 1991 Sep; 130(8):323-8. PubMed ID: 1801862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Particulate contamination in parenterals: current issues.
    Groves MJ
    Boll Chim Farm; 1991 Oct; 130(9):347-54. PubMed ID: 1799429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. USP perspectives on particle contamination of injectable products.
    Gallelli JF; Groves MJ
    J Parenter Sci Technol; 1993; 47(6):289-92. PubMed ID: 8120733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Method evaluation: automated microscopy as a compendial test for particulates in parenteral solutions.
    Barber TA; Lannis MD; Williams JG
    J Parenter Sci Technol; 1989; 43(1):27-47. PubMed ID: 2926604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining unnecessary disinfection procedures for single-dose and multiple-dose vials.
    Buckley T; Dudley SM; Donowitz LG
    Am J Crit Care; 1994 Nov; 3(6):448-51. PubMed ID: 7834004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbial barrier assessment of Tyvek stopper packaging for rubber closures.
    Moldenhauer JE; Bass SA; Kupinski MJ; Walters ML; Rubio SL
    PDA J Pharm Sci Technol; 1996; 50(6):391-8. PubMed ID: 9038086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Particulate matter in four reconstituted cephalosporin injections.
    Kilarski DJ; Visconti JA; Frank SG
    Am J Hosp Pharm; 1983 Apr; 40(4):619-23. PubMed ID: 6846372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Achieving "Zero" Defects for Visible Particles in Injectables.
    Johns J; Golfetto P; Bush T; Fantozzi G; Shabushnig J; Perry A; Degrazio F; Streich D; Miller J; Soukiassian H; Stanton A; Watson R
    PDA J Pharm Sci Technol; 2018; 72(6):640-650. PubMed ID: 30232141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A method for the determination of syringe needle punctures in rubber stoppers using stereoscopic light microscopy.
    Platek SF; Keisler MA; Ranieri N; Reynolds TW; Crowe JB
    J Forensic Sci; 2002 Sep; 47(5):986-92. PubMed ID: 12353585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approaches to reducing subvisible particle counts in lyophilized parenteral formulations.
    Gupta PK; Porembski E; Williams NA
    J Pharm Sci Technol; 1994; 48(1):30-7. PubMed ID: 8004415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new coincidence model for single particle counters, Part I: Theory and experimental verification.
    Knapp JZ; Abramson LR
    J Pharm Sci Technol; 1994; 48(3):110-34. PubMed ID: 8069513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determining Maximum Allowable Rubber Stopper Displacement for Container Closure Integrity (CCI).
    Nonis L; Vogt M; Joerg S; Mahler HC; Riesen F; Roidl G; Sabini F; Mathaes R
    PDA J Pharm Sci Technol; 2020; 74(6):688-692. PubMed ID: 32540864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.